U ntil recently, no treatments were available to help slow the progression of metabolic dysfunction–associated steatohepatitis (MASH), a severe form of fatty liver disease. But in March 2024, a ...

I really didn't see the death of short-acting beta-agonists (SABAs) coming. Sure, I'd read the SYGMA trials, [1,2] and yes, I was aware of lobbying from the "other side of the pond" (Europe). [3] So I ...

Please provide your email address to receive an email when new articles are posted on . TERN-501 6 mg, a thyroid hormone receptor beta agonist, reduced liver fat content in patients with nonalcoholic ...

Please provide your email address to receive an email when new articles are posted on . VK2809 significantly reduced liver fat vs. placebo at week 12, with results maintained at week 52. The thyroid ...

A recent systematic review evaluated 19 randomized placebo-controlled trials of long-acting beta-agonist (LABA) use for at least three months in 33,826 patients with asthma (Ann Intern Med.

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

This week, Dr Ray O’Connor takes a look at recent clinical articles on the management of asthma, and what environmental ...